J 2023

Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis

LUEBKE, Johannes, Juliana SCHWAAB, Deborah CHRISTEN, Hanneke Oude ELBERINK, Bart SPAN et. al.

Basic information

Original name

Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis

Authors

LUEBKE, Johannes, Juliana SCHWAAB, Deborah CHRISTEN, Hanneke Oude ELBERINK, Bart SPAN, Marek NIEDOSZYTKO, Aleksandra GORSKA, Magdalena LANGE, Karoline V GLEIXNER, Emir HADZIJUSUFOVIC, Oleksii SOLOMIANYI, Irena ANGELOVA-FISCHER, Roberta ZANOTTI, Massimiliano BONIFACIO, Patrizia BONADONNA, Khalid SHOUMARIYEH, von Bubnoff NIKOLAS, Sabine MUELLER, Cecelia PERKINS, Chiara ELENA, Luca MALCOVATI, Hans HAGGLUND, Mattias MATTSSON, Roberta PARENTE, Judit VARKONYI, Anna Belloni FORTINA, Francesca CAROPPO, Alexander ZINK, Knut BROCKOW, Christine BREYNAERT, Dominique BULLENS, Akif Selim YAVUZ, Michael DOUBEK (203 Czech Republic, belonging to the institution), Vito SABATO, Tanja SCHUG, Dietger NIEDERWIESER, Karin HARTMANN, Massimo TRIGGIANI, Jason GOTLIB, Olivier HERMINE, Michel AROCK, Hanneke C KLUIN-NELEMANS, Jens PANSE, Wolfgang R SPERR, Peter VALENT, Andreas REITER and Mohamad JAWHAR

Edition

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, AMSTERDAM, ELSEVIER, 2023, 2213-2198

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30205 Hematology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 9.400 in 2022

RIV identification code

RIV/00216224:14110/23:00133206

Organization unit

Faculty of Medicine

UT WoS

000993426200001

Keywords in English

Mastocytosis; Systemic mastocytosis; Organomegaly; Splenomegaly; Hepatomegaly; Lymphadenopathy

Tags

International impact, Reviewed
Změněno: 15/3/2024 13:41, Mgr. Tereza Miškechová

Abstract

V originále

BACKGROUND: Organomegaly, including splenomegaly, hepatomegaly, and/or lymphadenopathy, are important diagnostic and prognostic features in patients with cutaneous mastocytosis (CM) or systemic mastocytosis (SM).